Averitas Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AVERITAS, and what generic alternatives to AVERITAS drugs are available?
AVERITAS has one approved drug.
There are seven US patents protecting AVERITAS drugs.
There are sixty-nine patent family members on AVERITAS drugs in twenty-nine countries.
Summary for Averitas
| International Patents: | 69 |
| US Patents: | 7 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Averitas
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | 8,821,920 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | 8,889,113 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | 10,869,827 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | RX | Yes | Yes | 9,226,903 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Averitas
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | 10,463,598 | ⤷ Try a Trial |
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | 8,889,113 | ⤷ Try a Trial |
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | 8,263,059 | ⤷ Try a Trial |
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | 6,239,180 | ⤷ Try a Trial |
| Averitas | QUTENZA | capsaicin | PATCH;TOPICAL | 022395-001 | Nov 16, 2009 | 10,869,827 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Averitas Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Mexico | PA05011012 | ⤷ Try a Trial |
| Eurasian Patent Organization | 200500442 | ⤷ Try a Trial |
| European Patent Office | 1539124 | ⤷ Try a Trial |
| Eurasian Patent Organization | 012367 | ⤷ Try a Trial |
| Hungary | E042241 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
